🚀 VC round data is live in beta, check it out!
- Public Comps
- Dr. Martens
Dr. Martens Valuation Multiples
Discover revenue and EBITDA valuation multiples for Dr. Martens and similar public comparables like Guess, Azzas 2154, Grendene, Aditya Birla Fashion and more.
Dr. Martens Overview
About Dr. Martens
Dr. Martens PLC is engaged in the business of footwear. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives a majority of revenue from EMEA and also has a presence in the Americas and APAC.
Founded
2021
HQ

Employees
2.3K
Website
Sectors
Financials (LTM)
EV
$1B
Dr. Martens Financials
Dr. Martens reported last 12-month revenue of $1B and EBITDA of $205M.
In the same LTM period, Dr. Martens generated $673M in gross profit, $205M in EBITDA, and $52M in net income.
Revenue (LTM)
Dr. Martens P&L
In the most recent fiscal year, Dr. Martens reported revenue of $1B and EBITDA of $159M.
Dr. Martens expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Profit | $673M | XXX | $692M | XXX | XXX | XXX |
| Gross Margin | 64% | XXX | 65% | XXX | XXX | XXX |
| EBITDA | $205M | XXX | $159M | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 15% | XXX | XXX | XXX |
| EBIT Margin | 10% | XXX | 7% | XXX | XXX | XXX |
| Net Profit | $52M | XXX | $6M | XXX | XXX | XXX |
| Net Margin | 5% | XXX | 1% | XXX | XXX | XXX |
| Net Debt | — | — | $126M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Dr. Martens Stock Performance
Dr. Martens has current market cap of $880M, and enterprise value of $1B.
Market Cap Evolution
Dr. Martens' stock price is $0.91.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $880M | 0.0% | XXX | XXX | XXX | $0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDr. Martens Valuation Multiples
Dr. Martens trades at 1.2x EV/Revenue multiple, and 6.3x EV/EBITDA.
EV / Revenue (LTM)
Dr. Martens Financial Valuation Multiples
As of April 20, 2026, Dr. Martens has market cap of $880M and EV of $1B.
Equity research analysts estimate Dr. Martens' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Dr. Martens has a P/E ratio of 16.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $880M | XXX | $880M | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | 1.2x | XXX | 1.2x | XXX | XXX | XXX |
| EV/EBITDA | 6.3x | XXX | 8.1x | XXX | XXX | XXX |
| EV/EBIT | 12.3x | XXX | 17.0x | XXX | XXX | XXX |
| EV/Gross Profit | 1.9x | XXX | 1.9x | XXX | XXX | XXX |
| P/E | 16.9x | XXX | 143.9x | XXX | XXX | XXX |
| EV/FCF | 14.8x | XXX | 5.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Dr. Martens Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Dr. Martens Margins & Growth Rates
Dr. Martens' revenue in the last 12 month grew by 6%.
Dr. Martens' revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.3M for the same period.
Dr. Martens' rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Dr. Martens' rule of X is 31% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Dr. Martens Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | (2%) | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Growth | 15% | XXX | 28% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 25% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 31% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 58% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Dr. Martens Public Comps
See public comps and valuation multiples for other Clothing & Accessories comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Dr. Martens | XXX | XXX | XXX | XXX | XXX | XXX |
| Guess | XXX | XXX | XXX | XXX | XXX | XXX |
| Azzas 2154 | XXX | XXX | XXX | XXX | XXX | XXX |
| Grendene | XXX | XXX | XXX | XXX | XXX | XXX |
| Aditya Birla Fashion | XXX | XXX | XXX | XXX | XXX | XXX |
| Safari Indus (India) | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Dr. Martens M&A Activity
Dr. Martens acquired XXX companies to date.
Last acquisition by Dr. Martens was on XXXXXXXX, XXXXX. Dr. Martens acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Dr. Martens
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialDr. Martens Investment Activity
Dr. Martens invested in XXX companies to date.
Dr. Martens made its latest investment on XXXXXXXX, XXXXX. Dr. Martens invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Dr. Martens
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Dr. Martens
| When was Dr. Martens founded? | Dr. Martens was founded in 2021. |
| Where is Dr. Martens headquartered? | Dr. Martens is headquartered in United Kingdom. |
| How many employees does Dr. Martens have? | As of today, Dr. Martens has over 2K employees. |
| Who is the CEO of Dr. Martens? | Dr. Martens' CEO is Ije Nwokorie. |
| Is Dr. Martens publicly listed? | Yes, Dr. Martens is a public company listed on London Stock Exchange. |
| What is the stock symbol of Dr. Martens? | Dr. Martens trades under DOCS ticker. |
| When did Dr. Martens go public? | Dr. Martens went public in 2021. |
| Who are competitors of Dr. Martens? | Dr. Martens main competitors are Guess, Azzas 2154, Grendene, Aditya Birla Fashion. |
| What is the current market cap of Dr. Martens? | Dr. Martens' current market cap is $880M. |
| What is the current revenue of Dr. Martens? | Dr. Martens' last 12 months revenue is $1B. |
| What is the current revenue growth of Dr. Martens? | Dr. Martens revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Dr. Martens? | Current revenue multiple of Dr. Martens is 1.2x. |
| Is Dr. Martens profitable? | Yes, Dr. Martens is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Dr. Martens? | Dr. Martens' last 12 months EBITDA is $205M. |
| What is Dr. Martens' EBITDA margin? | Dr. Martens' last 12 months EBITDA margin is 20%. |
| What is the current EV/EBITDA multiple of Dr. Martens? | Current EBITDA multiple of Dr. Martens is 6.3x. |
| What is the current FCF of Dr. Martens? | Dr. Martens' last 12 months FCF is $87M. |
| What is Dr. Martens' FCF margin? | Dr. Martens' last 12 months FCF margin is 8%. |
| What is the current EV/FCF multiple of Dr. Martens? | Current FCF multiple of Dr. Martens is 14.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.